LabRoots and the Drug Discovery planning committee are pleased to announce the 4th Annual Drug Discovery & Development Virtual Conference. LabRoots will host this online-only event on February 24, 2021. The Drug Discovery planning committee will carefully plan and select speakers that best represent the key challenges, opportunities, and issues in the current landscape. These industry leaders will discuss the advancements, challenges and successes of discovery and develop new medications and therapies.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event. The webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global drug discovery community with a high degree of interaction through live-streaming video and chat sessions.
Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 Drug Discovery & Development Virtual Event. Submission is free. Submit your abstract here.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Use #LRdrug to follow the conversation!
As a recruiter with over 20 years of professional and executive search industry experience, Don Alexander has spent more than 16 years focusing exclusively on talent acquisition and recruiting, nationwide, for seasoned professionals in the Life Sciences sector (Biotechnology, Pharmaceutical, Medical Device, Diagnostics and supporting Services and Tools). He has successfully completed hundreds of recruitment projects that involved senior level individual contributors through C level executives, with particular emphasis on sales, business development, marketing, product development, project management and pre-clinical R&D. Throughout his recruiting career, Don has finished in the top 10% and consistently finished in the top 25% of his peer group, as ranked by revenues. An enabler of relationships that have resulted in quantifiable goodwill for his constituency, he is recognized by clients, candidates, and colleagues for routinely creating value through a robust network and deep industry perspective. Prior to working at the intersection of Life Sciences and recruiting, Don spent the first years of his career in the financial sector managing millions of dollars in assets. This uncommon background, and breadth of business knowledge, enables Don to understand the recruitment process in a much larger context than just the placement of a single individual. It’s about a business investing in its growth—and mitigating risks. In addition to actively volunteering to help others, he enjoys rooting for NCSU, reading, investing, traveling and playing guitar. He even played “Stairway to Heaven” in his high school band but that was a while ago.
Roger Hayes, PhD, is the Vice President of Bioanalytical Services with the ICON Laboratory Services group. Roger joined ICON (Dublin, Ireland) in December of 2018. In this role, Roger holds overall management responsibility for our bioanalytical laboratory in Whitesboro, New York supporting pharmacokinetic, pharmacodynamic, immunogenicity and biomarker assays for large- and small-molecule drug development. Dr Hayes has held numerous leadership positions in the global life sciences industry and academia, leading teams in the development of state-of-the-art bioanalytical and analytical techniques, including mass spectrometry, chromatography, immunology and automation in bringing medical and chemical products to market. For nearly two decades, he led strategic and research initiatives for large pharmaceutical companies that included both GLP and non-GLP preclinical studies as well as clinical trials.
As VP of Nonclinical Sciences, Joseph Senn oversees all nonclinical development, Toxicology, pathology, DMPK, Clinical pharmacology and in vivo pharmacology, across Moderna and its ventures. Prior to joining Moderna, Dr. Senn was director and site head for Drug Safety Evaluation and therapeutic area lead for immunology at Takeda Pharmaceuticals. . Dr. Senn is a board certified toxicologist who received his PhD in Pharmacology and Physiology from the University of Rochester School of Medicine and Dentistry. He has held joint faculty positions at the Medical University of South Carolina as assistant professor of pediatrics and pharmacology prior to entering industry. In industry, his focus has been on immunotoxicology, investigative, discovery and development toxicology. Over his time in industry he has supported the development of programs in a wide range of therapeutic areas including immune modulators, oncology, neurology, inflammatory and infectious diseases. He has led multiple regulatory filings for modalities ranging from small molecules, biologics and antibody drug conjugates and most recently modified messenger RNA.
Dr. Mark Kiel is Co-Founder and Chief Science Officer at Genomenon, where he oversees the company's scientific direction and product development. After spending 15 years preparing for a life of academic research, Mark became convinced that revolutionary change in genomics was more likely to emerge out of industry. In 2014, he founded Genomenon - an A.I.-driven life science company addressing the challenge of connecting pharma researchers with evidence in the literature to help diagnose and treat patients with genetic diseases and cancer.
After receiving his PhD on membrane biology and biophysics, Dr. Christian Klose did a post-doc on mass spectrometry-based lipidomics. In his role as CTO, Christian focusses on the development of novel shotgun lipidomics technology and is responsible for product development and regulatory affairs.
Steven Anderson is senior vice president and chief scientific officer for Covance Drug Development. He has worked for LabCorp for 30 years and has held a variety of positions, including director of operations for ViroMed Laboratories, director of operations for Monogram Biosciences, director of operations for the Center for Molecular Biology and Pathology, director of operations for Integrated Oncology and Integrated Genetics, national director of research and development, and global head of LabCorp Clinical Trials. His research interests include Molecular Pathology and Oncology based biomarkers, and that work has resulted in the development and validation of multiple companion diagnostics and pharmacogenomic assays in clinical use today. He holds a doctorate in genetics from Iowa State University and was an American Cancer Society postdoctoral fellow at the Waksman Institute of Microbiology at Rutgers University.
Dr. Reid Olsen is the head of GPCR Pharmacology at Exscientia Ltd. (Exscientia.ai), an AI-driven drug discovery biotechnology in Oxford, England. Dr. Olsen received his Ph.D. from the University of North Carolina at Chapel Hill under the mentorship of Dr. Bryan Roth. Dr. Olsen’s research spans multiple domains within pharmacology and neurobiology, but has been primarily focused on the development of biological tools for the study of GPCR signaling in vitro and in vivo.
Dr. Marsha Pierce is an assistant professor at Midwestern University where she studies the role of oxytocin analogs in cellular signaling and neuronal morphology and marine natural products in neuroscience drug development. Dr. Pierce received her BS in biology and MS and PhD in biomedical sciences at Creighton University. Her postdoctoral research examined the role of natural variation in oxytocin and vasopressin ligands and receptors on pharmacological signaling profiles under the mentorship of Thomas Murray at Creighton University.
Dr Roche has a Degree and PhD from Trinity College Dublin and has since accumulated 20 years experience within the clinical trials industry with particular focus on the intricacies of biomarkers, associated laboratory methods and their ability to facilitate an efficient and accurate assessment of the clinical safety and efficacy of therapeutics moving through clinical trials.
Cynthia Rohde is currently an Associate Research Fellow in the Drug Safety Research and Development department at Pfizer, Inc. She been a drug development research scientist in the pharmaceutical industry for over 13 years with experience across various therapeutic areas and modalities, but is current focusing on Oncology therapies and Vaccines. Cynthia received her PhD in Biochemistry from the University of Wisconsin-Madison and is a Diplomate of the American Board of Toxicology.
Cindy Spittle is the Vice President of Scientific Affairs within the ICON Laboratory Services group. Dr. Spittle has over 30 years of experience in translational and clinical oncology biomarker research, diagnostic assay development and biomarker strategy for clinical drug development. She provides strategic scientific leadership related to the evaluation and implementation of new technologies and laboratory testing services.
GenScript is the leading gene, peptide, protein and antibody research partner for fundamental life science research, translational biomedical research, and early stage pharmaceutical development. Since our establishment in 2002, GenScript has exponentially grown to become a ...See more See less
As the scientific community races to solve this evolving global health crisis, Twist Bioscience is proud to carry on as an active partner for all of your research needs. Twist's unique silicon-based DNA writing platform allows for the rapid development of NGS panels for viral ...See more See less
Visiopharm® is a world leader in Augmented Pathology™ solutions; that comprise precision pathology and high-throughput pathology for tissue-diagnostics and research. Leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and ...See more See less
Analytik Jena is a provider of instruments and products in the areas of analytical measuring technology and life science. Its portfolio includes the most modern analytical technology and complete systems for bioanalytical applications in the life science area. Comprehensive ...See more See less
Sino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers ...See more See less
The Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and ...See more See less
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic ...See more See less
NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications ...See more See less
POSTER SUBMISSION GUIDELINES
Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PDF file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.
SUBMIT YOUR ABSTRACT
Enter the following information to this Submission Form:
All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.
If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.
Questions? Email Posters@LabRoots.com
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
An Associate Professor with Midwestern University, and adjunct faculty member at Northwestern University Dr. Annette Gilchrist has a PhD in Immunology from the University of Connecticut Health Center and a MS in Biochemistry from the University of Connecticut. Previously, she ...See more See less
Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...See more See less
Between 1994-2015 he worked at EKF Diagnostics in Wales (formerly Argutus Medical) where he introduced and promoted a wide range of novel kidney and liver tests, including important biomarkers that are now being evaluated by the IMI (Innovative Medicines Initiative) and FDA as ...See more See less
Leading Novabiosis' primary cell business, Matthew brings to the Company a skill for implementing sales-driven business strategies, an extensive track record of meeting and surpassing targeted sales objectives, and a passion for translating customer needs into solutions that ...See more See less
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events
Research And Development
LabRoots Registration (Also interested in)31%
WAVE Newsletter Promotion7%
Social Media Promotions2%
Trending Newsletter Promotion1%
Medical Laboratory Technician9%
Clinical Laboratory Scientist3%
Life Science Company2%
Contract Research Organization (Cro)2%